Search
for
Sort by
Research 241–270 of 1000+
- Metabolic Aspects of Polycystic Ovary Syndrome
- Characterization of lipid profile in psoriasis, acne vulgaris, and androgenetic alopecia: a case–control study
- History of discovery of polycystic ovary syndrome
- Alopecia: the case for medical necessity.
- There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses
- Peri-operative Antithrombotic Therapy in Hair Transplantation
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- Highlights
- Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study
- Does a male polycystic ovarian syndrome equivalent exist?
- Male hormonal contraception: looking back and moving forward
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Topical and oral minoxidil for hair disorders in pediatric patients: What do we know so far?
- Long-lived proteins and DNA as candidate predictive biomarkers for tissue associated diseases
- Eficacia y Seguridad de Metformina sobre el patrón clínico y metabólico en el Síndrome de Ovario Poliquístico: Revisión Sistemática y Metaanálisis
- Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality
- A study to assess the co-morbidities and complications of polycystic ovarian syndrome
- Transsexualism
- Association of Dyslipidemia and Androgenetic Alopecia: A Case Control Study
- Androgenetic Alopecia From A to Z
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- No increased risk of CV events with dutasteride vs finasteride
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Pathogenesis of Cardiovascular Alterations in Dogs Treated with Minoxidil
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Repurposing of approved cardiovascular drugs
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology